NEW BRUNSWICK, N.J., March 12 /PRNewswire-FirstCall/ -- Johnson & Johnson will provide a pre-recorded webcast for financial analysts on Sunday, March 15 at 10:00 a.m. (Eastern Time) to coincide with the World Institute of Pain 5th World Congress (WIP) in New York City. Phase 3 clinical data on investigational tapentadol extended release (ER), a novel centrally acting oral analgesic, will be presented for the first time in a poster session at WIP.
A pre-recorded Webcast, with the lead tapentadol researchers, will be made available concurrent to the data presentations being made during the poster session at WIP. Pre-registration is not required to view the webcast/podcast.
The presentation will provide an overview on tapentadol and review data from the following clinical posters:
The webcast/podcast and replay can be accessed by clicking on "Webcasts/Presentations" in the Investor Relations section of the Company's website at http://www.jnj.com.
CONTACT: Jeffrey J. Leebaw, +1-732-524-3350, +1-732-642-6608, Mobile, or
Bill Price, +1-732-524-6623, +1-732-668-3735, Mobile; or Investors, Louise
Mehrotra, +1-732-524-6491, or Lesley Fishman, +1-732-524-3922
Web site: http://www.jnj.com/
